Nektar Therapeutics NKTR

$73.02 -3.82% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-14 View →
8-K CURRENT REPORT 2026-08-13 View →
4 4 2026-07-24 View →
4 4 2026-07-24 View →
4 4 2026-07-02 View →
4 4 2026-06-18 View →
4 4 2026-06-17 View →
8-K CURRENT REPORT 2026-06-05 View →
4 4 2026-05-21 View →
4 4 2026-05-21 View →
424B5 424B5 2026-05-08 View →
8-K 8-K 2026-05-08 View →
10-Q 10-Q 2026-05-08 View →
8-K CURRENT REPORT 2026-05-07 View →
DEF 14A DEF 14A 2026-04-24 View →
8-K 8-K 2026-04-23 View →
424B5 424B5 2026-04-23 View →
424B5 424B5 2026-04-20 View →
8-K 8-K 2026-04-20 View →
8-K 8-K 2026-04-20 View →
10-K 10-K 2026-03-13 View →
8-K CURRENT REPORT 2026-03-12 View →
4 4 2026-02-20 View →
4 4 2026-02-20 View →
8-K 8-K 2026-02-13 View →
424B5 424B5 2026-02-13 View →
424B5 424B5 2026-02-10 View →
8-K 8-K 2026-02-10 View →
8-K 8-K 2026-02-10 View →
8-K CURRENT REPORT 2026-01-27 View →
4 4 2026-01-22 View →
4 4 2025-12-23 View →
4 4 2025-12-23 View →
8-K 8-K 2025-12-16 View →
4 4 2025-11-25 View →
4 4 2025-11-25 View →
4 4 2025-11-25 View →
8-K CURRENT REPORT 2025-11-21 View →
424B5 424B5 2025-11-12 View →
8-K CURRENT REPORT 2025-11-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$73.02
Market Cap
$2.57 billion
52-Week Range
$21.02 – $109.00
Average Volume
734K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.